Authors
Latest:
Study Finds Disparities in Access to Patient Portals Despite a Rise in UseThe study found that white patients were offered access to patient portals more frequently than Black or Hispanic patients.
Latest:
Improve Patient Outcomes With Better Language AccessMedical practices can choose from a wide array of tools to enable communication with patients from diverse backgrounds.
Latest:
Missed Diagnoses, Missed Opportunities: Closing the Gap in Skin Cancer for Patients of ColorExplore the urgent need for improved skin cancer awareness and care for minority populations, addressing disparities in diagnosis and treatment.
Latest:
Apoptosis-Based Skin Cancer Treatment Shows PromiseChristopher B. Zachary, MBBS, MRCP, FRCP, shares insights in apoptosis-based skin care treatment.
Latest:
The Role of Pharmacists in Providing Patient Counseling On Topical Niacinamide For Acne and MoreNiacinamide is a versatile skincare ingredient that effectively targets acne, age-related issues, hyperpigmentation, and atopic dermatitis, writes Anjeza Fero, PharmD, RPh.
Latest:
Benzoyl Peroxide and Benzene: Latest findings from John Barbieri, MD, MBA, FAADResearchers behind the latest benzene studies found no increased cancer risk with use of products containing benzoyl peroxide.
Latest:
Opening Doors of Communication: Social Media Trends and ChallengesLuke Maxfield, DO, discusses the importance of understanding social media trends and engaging patients in dialogues.
Latest:
Sunscreen Innovations: Addressing Diverse Photoprotection Needs and Future Directions in Preventive DermatologyDr Darrel Rigel provides insights into cutting-edge photoprotection strategies, emphasizing the specific considerations for skin of color patients and the critical role of sunscreen in preventive dermatology.
Latest:
Omicron COVID-19 variant: What we know and what we don’tThe Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.
Latest:
Andrew Baker, MBA, MPAS, PA-C, Shares Vision for SDPA LeadershipStrengthening interdisciplinary relationships remains a central part of Baker’s focus.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Nkem Ugonabo, MD, MPH, and Adelle Infante: Mentorship of Young Women and Girls in STEM, DermatologyAllergan Aesthetics recently announced the fifth-year of its partnership with Girls Inc. Nkem Ugonabo, MD, MPH, and Adelle Infante recently spoke with Dermatology Times to discuss the importance of STEM and dermatology mentorship.
Latest:
Higher Treatment, Health Care Costs Associated With Advanced MelanomasGreater treatment costs are associated with more advanced stages of melanoma, particularly due to increasing prices of treatments.
Latest:
Optimizing Patient Outcomes with JAK InhibitorsBrett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
Latest:
Case Report: Repigmentation of the Lips Using RuxolitinibDive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.
Latest:
Key Takeaways for the Management of Plaque PsoriasisExperts in dermatology share final thoughts on the treatment of plaque psoriasis and the ever-changing treatment landscape.
Latest:
Cutiss, DenovoSkin Changing the Standard of Burn Care Across the GlobeCEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.
Latest:
Upadacitinib Demonstrates Efficacy in Patients With AD and Head and Neck InvolvementKilian Eyerich, MD, PhD, shares insights into an EADV 2024 presentation on upadacitinib’s ability to achieve almost total skin clearance in the head and neck regions with minimal effect on quality of life.
Latest:
Additional Medicaid Expansion Would Provide Advantages to Patients With MelanomaDuring the 2024 American Society of Clinical Oncology annual meeting, a poster highlighted the advantages Medicaid expansion could offer to individuals with melanoma.
Latest:
Developing an OTC Dermatology ProductRenata Block, MMS, PA-C, and Erica Ramos, PA-C, discuss the complexities of developing an over-the-counter hair product.
Latest:
Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis ManagementA panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.
Latest:
Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, AcneDermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Latest:
Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMSBar will share insight on foldover interpolated flaps for full thickness of nasal defects.
Latest:
New, Difficult-to-Treat Fungal Skin Infections Are Emerging, Clinicians WarnTwo new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.
Latest:
Jeremy Brauer, MD, Publishes Men’s Aesthetics TextbookBrauer’s textbook can be purchased through Amazon and Barnes & Noble.
Latest:
Can Supplements Effectively Manage Hair Loss?Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.
Latest:
Assessing Quality of Life and AAD Research ConsiderationsAlan Irvine, MD, DSc, shares insights on the impact of ruxolitinib on quality of life in pediatric patients and 2024 AAD research presentations to take into consideration.
Latest:
Insights Into Positive Decision for Galderma's RelabotulinumtoxinA in EuropeSachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.
Latest:
Striving for Melanoma Advancements With the Melanoma Research AllianceMarc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.
